Welcome to this issue of the C-DIAS Bimonthly newsletter! Please share with colleagues, friends, and anyone else you know who might be interested in our work and encourage them to subscribe to our newsletter. | |
News from the C-DIAS Research Core | | |
|
The Design & Modeling Section is advancing three manuscripts on rollout and stepped-wedge designs. The section is also developing a web-based R-Shiny tool for researchers to describe and visualize rollout trial designs for collaborating with community partners.
| | |
|
The Methods & Measures Section is collaborating on a universal fidelity measure for both interventions and implementation strategies. The measure is now in the piloting phase with the C-DIAS research project, Addressing Barriers to Care for Substance Use Disorder Pilot Study (ABC-SUD).
| | |
|
The Policy & Financing Section is launching a dashboard that displays national and state-by-state Medicaid fee-for-service rates for substance use disorder treatment providers, policymakers, health plan administrators, and chief financial officers to evaluate coverage and examine variability. Faculty from the Design & Modeling and Policy & Financing Sections, Dr. Lindsey Zimmerman and Dr. Erika Crable, are collaborating to explore data and modeling simulations potentially useful for decision-making by Center for Medicare and Medicaid Services (CMS).
| |
C-DIAS Research Project Updates | | |
|
County-level model-driven approach to reduce overdose death
The research team has just published two articles. Model-driven decision support: A community-based meta-implementation strategy to predict population impact (Johnson et al., 2024) presents a community-focused approach using agent-based modeling to enhance public health decision making. They propose predictive modeling to answer "what-if" scenarios and the impact of implementation and resource allocations on overdose deaths. Overdose deaths before and during the COVID-19 pandemic in a US county (Brown et al., 2024) examines the impact of the COVID-19 pandemic on drug overdose deaths in a US county. Mortality increased attributable to alcohol, heroin, fentanyl, amphetamines, and/or cocaine.
Collaborations and data collection are underway with Pinellas County (Florida), Santa Clara County (California), and Vermillion County (Illinois).
| | |
|
Behavioral incentives for persons with stimulant use disorder
In addition to the ongoing project implementing contingency management with opioid treatment programs across the state of Rhode Island, the project team is extending an exciting new collaboration with the Chicago Department of Public Health. They are co-designing a contingency management implementation initiative for behavioral health organizations.
Dr. Sara Becker (Project PI) recently published an invited commentary in the journal Addiction, Contingency management needs implementation science. Contingency management (CM) is a highly effective addiction treatment that is underused in the US due to funding, policy restrictions, and stigma. Becker sounds a call to action emphasizing that implementation science can transform access to CM.
| | |
|
Addressing Barriers to Care for Substance Use Disorder Pilot Study (ABC-SUD)
Within the context of the Kaiser Permanente Northwest Health System, twenty patient interviews have been completed. This process informs the development of a care navigation intervention. In a user-centered design approach, additional interviews will be conducted with Spanish-speaking patients and primary and specialty care providers. Care navigation supports patients in accessing and successfully linking to specialty addiction treatment services, and it targets both motivational and logistical challenges (e.g., long wait times, lack of transportation). The team is analyzing the discourse from all interviews using the Rapid Group Analysis Process. The pilot trial for the care navigation intervention started on July 9th.
| |
C-DIAS Fellow
In The Spotlight
| |
Andrea Jakubowski, MD, MS | |
|
Andrea Jakubowski, MD, MS, is a 2023-2025 C-DIAS Fellow. She is a general internist and addiction medicine specialist at Montefiore Medical Center-Albert Einstein College of Medicine. Dr. Jakubowski provides low-threshold buprenorphine treatment in a syringe services program (SSP), opioid use disorder treatment in an opioid treatment program, and cares for patients on a hospital addiction consult service. Her research focuses on expanding access to opioid use disorder medications, including studying buprenorphine treatment in SSP and improving hospital-based opioid use disorder care and naloxone distribution. Currently, Dr. Jakubowski and her team are studying injectable buprenorphine implementation in a Primary Care and Low Threshold clinic using implementation science methods.
For Dr. Jakubowski's K23 on implementing LAI-bupe, she has been meticulously tracking implementation strategies using C-DIAS tools, ensuring the use of established methods. To enhance her project, Dr. Jakubowski incorporated the EPIS framework to describe the implementation process, even though it was not part of her original proposal. Andrea has also deepened her understanding of the implementation science (IS) community by attending IS-focused conferences and networking events. For the first time, Dr. Jakubowski submitted an abstract to the 2024 Addiction Health Services Research (AHSR) Conference and plans to attend Academy Health in December 2024. Lastly, she continues to apply her learning by reviewing IS manuscripts and conference abstracts, as well as providing feedback on IS methods for colleagues' grant proposals.
Andrea Jakubowski and Briana Patrick, a Project Coordinator on C-DIAS, are preparing a manuscript for the upcoming special issue of Implementation Science Communications, focusing on "Generalizing and Context in Implementation Research: Tensions and Opportunities”. Their manuscript describes the use of the Inventory of Factors Affecting Successful Implementation and Sustainment (IFASIS), a novel instrument developed by C-DIAS. The IFASIS was used to identify barriers and facilitators to implementing a digital contingency management tool across six opioid treatment programs in C-DIAS research project, Behavioral incentives for persons with stimulant use disorder. Additionally, the authors explain how the baseline IFASIS results were used to tailor implementation facilitation.
| |
C-DIAS Learning Opportunities | |
C-DIAS Virtual Grand Rounds
The C-DIAS Virtual Grand Rounds will resume Fall of 2024. Twice-monthly, invited presenters describe innovative implementation research in addiction treatment, or cutting edge methods applicable to address addiction public health.
Missed a Fall 2023 or Spring 2024 session? No worries! Grand Rounds recordings can be found here.
If you or anyone you know would like to present, please contact Dr. Helene Chokron Garneau at hchokgar@stanford.edu, and she can assist in getting you scheduled.
Don't forget to register to our listserv to receive updates on future sessions.
|
|
NIDA Clinical Trials Network Translation & Implementation Special Interest Group | |
|
|
The C-DIAS hosted Special Interest Group (SIG) meets bimonthly via Zoom at noon Eastern on the third Tuesday of the month. The SIG spawned two active workgroups that meet ad hoc. Drs. Jennifer McNeely and Joseph Glass co-chair the Implementation Outcomes workgroup, and Drs. Jennifer Becan and Brian Hartzler co-chair the Implementation Strategies work group.
At the next SIG meeting (July 16), Dr. Matthew Aalsma will present on collaborative efforts across legal and community treatment systems in Indiana, aimed at enhancing engagement in substance use services. Dr. Aalsma emphasizes the crucial need for a unified approach to improve how treatment services refer to, engage, and retain individuals with substance use disorders.
| |
Upcoming SIG webinars:
July 16, 2024 (9am PT): The cross system collaboration to improve engagement in substance use services (Matthew Aalsma, PhD). Download the agenda here.
September 17, 2024 (9am PT): Dr. Kelly A. Aschbrenner (title TBA).
Contact Helene Chokron Garneau at hchokgar@stanford.edu if you would like to attend!
| |
What Are We Reading and Listening To? | | |
|
We Want to Hear Your Voice!
Did you learn something new or hear something inspiring during a recent talk, presentation, or event that you recently attended? We want to hear from you! Please submit your thoughts, musings, or quotes to info@c-dias.org.
| |
|
REGISTER TODAY!
Addiction Health Services Research Conference
| |
|
The Center for Dissemination and Implementation (CDI) at Stanford University School of Medicine is honored to host the annual Addiction Health Services Research (AHSR) conference, October 16-18, 2024, in San Francisco, CA. Early bird registration is still open until July 31 at 11:59 PM PT. Click here to register now!
Sign up for the AHSR listserv to get updates and alerts on information, such as Pre-Conference Workshops and Plenary speakers. Sign up here.
| |
Let's Stay in Touch
You are receiving this email because you either subscribed to receive updates from us or someone you know thinks you'd be interested in our work. If this email was forwarded to you, please subscribe to our newsletter so you can continue getting updates.
| | | | |
